Marianna H. Almanza, PA-C

Marianna Almanza practices at Hodari MD Dermatology in Yuba City, California.

Marianna Almanza's NPI, 1720542491, was assigned on January 28, 2019. Marianna Almanza holds California license 56150.

Marianna Almanza's primary practice is Hodari MD Dermatology, at 1178 Live Oak Blvd, Yuba City, CA 95991 in Sutter County. The practice phone is (530) 342-3686.

Marianna Almanza's primary practice is Hodari MD Dermatology in Yuba City, California. Marianna Almanza is also affiliated with Oroville Hospital. The medical group on file is Hodari MD Dermatology & Rejuvené. Dmand AI also links Marianna Almanza to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Marianna Almanza practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Marianna Almanza's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Marianna Almanza is licensed in California.

Dmand AI lists acne, acute skin infection, ankle or foot injury, anxiety, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis and facial skin infection among the conditions Marianna Almanza treats.

CMS data shows 3,173 Medicare services from Marianna Almanza across 15 procedure codes in 2024, for 433 Medicare patients. Medicare paid $124,361 for them. Every service was in an office.

CMS counts 433 Medicare patients who saw Marianna Almanza in 2024. The largest group is 65 to 74, with 228 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Marianna Almanza's median patient age at 64, with 63% women.

In 2024, Marianna Almanza wrote 414 Medicare Part D claims for 176 patients. 88% of them were for generic drugs. CMS names the drug for 328 of them, across 11 drugs with 11 or more claims each, at $158,601 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Marianna Almanza for performance year 2024, reported as part of a group. Marianna Almanza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 75 general payments to Marianna Almanza from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $669.